Salubris Pharmaceuticals

Business focus

MedTech, BioTech & Pharma

Description

Shenzhen-based pharmaceutical company founded in 1998, focused on cardiovascular and other prescription drugs. Its flagship product is Taijia (clopidogrel bisulfate tablets), a generic equivalent of Sanofi's Plavix that holds over 30% market share by value; it also develops antihypertensive drugs (allisartan) and biologics.